IGKV2D-29 and type 1 diabetes mellitus: Surprisingly, a high prevalence (88%) of anti-amylase α-2A was detected in patients with fulminant type 1b diabetes mellitus, which is a form of diabetes with an absence of autoantibodies typical for type 1 diabetes mellitus (T1DM) [23].